The unfolded protein response and the phosphorylations of activating transcription factor 2 in the trans-activation of il23a promoter produced by β-glucans

J Biol Chem. 2014 Aug 15;289(33):22942-22957. doi: 10.1074/jbc.M113.522656. Epub 2014 Jun 30.

Abstract

Current views on the control of IL-23 production focus on the regulation of il23a, the gene encoding IL-23 p19, by NF-κB in combination with other transcription factors. C/EBP homologous protein (CHOP), X2-Box-binding protein 1 (XBP1), activator protein 1 (AP1), SMAD, CCAAT/enhancer-binding protein (C/EBPβ), and cAMP-response element-binding protein (CREB) have been involved in response to LPS, but no data are available regarding the mechanism triggered by the fungal mimic and β-glucan-containing stimulus zymosan, which produces IL-23 and to a low extent the related cytokine IL-12 p70. Zymosan induced the mobilization of CHOP from the nuclear fractions to phagocytic vesicles. Hypha-forming Candida also induced the nuclear disappearance of CHOP. Assay of transcription factor binding to the il23a promoter showed an increase of Thr(P)-71-Thr(P)-69-activating transcription factor 2 (ATF2) binding in response to zymosan. PKC and PKA/mitogen- and stress-activated kinase inhibitors down-regulated Thr(P)-71-ATF2 binding to the il23a promoter and il23a mRNA expression. Consistent with the current concept of complementary phosphorylations on N-terminal Thr-71 and Thr-69 of ATF2 by ERK and p38 MAPK, MEK, and p38 MAPK inhibitors blunted Thr(P)-69-ATF2 binding. Knockdown of atf2 mRNA with siRNA correlated with inhibition of il23a mRNA, but it did not affect the expression of il12/23b and il10 mRNA. These data indicate the following: (i) zymosan decreases nuclear proapoptotic CHOP, most likely by promoting its accumulation in phagocytic vesicles; (ii) zymosan-induced il23a mRNA expression is best explained through coordinated κB- and ATF2-dependent transcription; and (iii) il23a expression relies on complementary phosphorylation of ATF2 on Thr-69 and Thr-71 dependent on PKC and MAPK activities.

Keywords: ATF2; Cyclic AMP (cAMP); Dendritic Cell; ER Stress; Fungal Infection; IL-23; Prostaglandin E2; Unfolded Protein Response (UPR); cAMP-response Element-binding Protein (CREB); β-Glucans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 2 / genetics
  • Activating Transcription Factor 2 / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Extracellular Signal-Regulated MAP Kinases / genetics
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Interleukin-23 Subunit p19 / biosynthesis*
  • Interleukin-23 Subunit p19 / genetics
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Phosphorylation / drug effects
  • Phosphorylation / physiology
  • Promoter Regions, Genetic / physiology*
  • Protein Kinase C / genetics
  • Protein Kinase C / metabolism
  • Transcriptional Activation / drug effects*
  • Transcriptional Activation / physiology
  • Unfolded Protein Response / drug effects*
  • Unfolded Protein Response / physiology
  • Zymosan / pharmacology*

Substances

  • ATF2 protein, human
  • Activating Transcription Factor 2
  • IL23A protein, human
  • Interleukin-23 Subunit p19
  • Zymosan
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C
  • Extracellular Signal-Regulated MAP Kinases